Literature DB >> 28258460

Evaluation of Gastroesophageal Reflux Disease.

P Marco Fisichella1, Ciro Andolfi2, George Orthopoulos3.   

Abstract

INTRODUCTION: Gastroesophageal reflux disease (GERD) may present with heartburn, regurgitation, dysphagia, chronic cough, laryngitis, or even asthma. The clinical presentation of GERD is therefore varied and poses certain challenges to the physician, especially given the limitations of the diagnostic testing. DISCUSSION: The evaluation of patients with suspected GERD might be challenging. It is based on the evaluation of clinical features, objective evidence of reflux on diagnostic testing, correlation of symptoms with episodes of reflux, evaluation of anatomical abnormalities, and excluding other causes that might account for the presence of the patient's symptoms.
CONCLUSIONS: The diagnostic evaluation should include multiple tests, in addition to a thorough clinical examination.

Entities:  

Mesh:

Year:  2017        PMID: 28258460     DOI: 10.1007/s00268-017-3953-3

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  39 in total

1.  Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication.

Authors:  G M Campos; J H Peters; T R DeMeester; S Oberg; P F Crookes; S Tan; S R DeMeester; J A Hagen; C G Bremner
Journal:  J Gastrointest Surg       Date:  1999 May-Jun       Impact factor: 3.452

2.  Pulmonary immune changes early after laparoscopic antireflux surgery in lung transplant patients with gastroesophageal reflux disease.

Authors:  P Marco Fisichella; Christopher S Davis; Erin Lowery; Matthew Pittman; James Gagermeier; Robert B Love; Elizabeth J Kovacs
Journal:  J Surg Res       Date:  2012-04-18       Impact factor: 2.192

3.  Esophageal motor dysfunction and gastroesophageal reflux are prevalent in lung transplant candidates.

Authors:  Benjamin Basseri; Jeffrey L Conklin; Mark Pimentel; Robert Tabrizi; Edward H Phillips; Sinan A Simsir; George E Chaux; Jeremy A Falk; Sara Ghandehari; Harmik J Soukiasian
Journal:  Ann Thorac Surg       Date:  2010-11       Impact factor: 4.330

4.  Impact of delayed gastric emptying on the outcome of antireflux surgery.

Authors:  J E Bais; M Samsom; E A Boudesteijn; P P van Rijk; L M Akkermans ; H G Gooszen
Journal:  Ann Surg       Date:  2001-08       Impact factor: 12.969

5.  Importance of esophageal manometry and pH monitoring for the evaluation of otorhinolaryngologic (ENT) manifestations of GERD. A multicenter study.

Authors:  Fernando A M Herbella; Ciro Andolfi; Yalini Vigneswaran; Marco G Patti; Bruno R Pinna
Journal:  J Gastrointest Surg       Date:  2016-07-25       Impact factor: 3.452

6.  Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.

Authors:  G Galindo; J Vassalle; S N Marcus; G Triadafilopoulos
Journal:  Dis Esophagus       Date:  2012-08-02       Impact factor: 3.429

7.  A new method for determining gastric acid output using a wireless pH-sensing capsule.

Authors:  D H Weinstein; S deRijke; C C Chow; L Foruraghi; X Zhao; E C Wright; M Whatley; R Maass-Moreno; C C Chen; S A Wank
Journal:  Aliment Pharmacol Ther       Date:  2013-05-03       Impact factor: 8.171

8.  Pepsin concentrations are elevated in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis after lung transplantation.

Authors:  Christopher S Davis; Bernardino M Mendez; Diana V Flint; Karen Pelletiere; Erin Lowery; Luis Ramirez; Robert B Love; Elizabeth J Kovacs; P Marco Fisichella
Journal:  J Surg Res       Date:  2013-06-29       Impact factor: 2.192

Review 9.  The role of impaired esophageal and gastric motility in end-stage lung diseases and after lung transplantation.

Authors:  Piero Marco Fisichella; Anahita Jalilvand
Journal:  J Surg Res       Date:  2013-10-08       Impact factor: 2.192

10.  The Reflux Disease Questionnaire: a measure for assessment of treatment response in clinical trials.

Authors:  Michael Shaw; John Dent; Timothy Beebe; Ola Junghard; Ingela Wiklund; Tore Lind; Folke Johnsson
Journal:  Health Qual Life Outcomes       Date:  2008-04-30       Impact factor: 3.186

View more
  2 in total

1.  Dynorphin participates in interaction between depression and non-erosive reflux disease.

Authors:  Yi Wang; Bingduo Zhou; Shengquan Fang; Shengliang Zhu; Tingting Xu; Makan Dilikumaer; Guanwu Li
Journal:  Esophagus       Date:  2022-10-16       Impact factor: 3.671

2.  Intra-Esophageal pH Monitoring on Two Consecutive Days in Patients With Gastroesophageal Reflux Symptoms.

Authors:  Andrea de Oliveira Batista; Adriana Zanoni Dotti; Lilian Rose Otoboni Aprile; Roberto Oliveira Dantas
Journal:  Gastroenterology Res       Date:  2019-08-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.